Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. - Wikidata - awgldk - TriplyDB

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

http://www.wikidata.org/entity/Q36759184

about

Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment.Smoking and increased Alzheimer's disease risk: a review of potential mechanisms Counseling athletes on the risk of chronic traumatic encephalopathy BioAge: toward a multi-determined, mechanistic account of cognitive aging.Molecular imaging of Alzheimer disease pathology Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.Predicting cognitive function from clinical measures of physical function and health status in older adults.Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.Tau imaging in neurodegenerative diseases.Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.Nonvascular retinal imaging markers of preclinical Alzheimer's disease.Vascular risk and FDDNP-PET influence cognitive performance.Youthful Processing Speed in Older Adults: Genetic, Biological, and Behavioral Predictors of Cognitive Processing Speed Trajectories in Aging.Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity.Talking with parents of high school football players about chronic traumatic encephalopathy: a concise summary.Amyloid imaging in Alzheimer's disease: a literature review.Amyloid-beta and depression in healthy older adults: a systematic review.Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status.Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints.Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.Healthy behavior and memory self-reports in young, middle-aged, and older adults.How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.Testosterone effect on brain metabolism in elderly patients with Alzheimer's disease: comparing two cases at different disease stages.

P2860

Q30666527-2EEAC899-BA59-4A71-B85B-E63BC02018D1 Q31096423-7FAEA93F-05F3-4126-AC7D-136915A1DA0F Q33850834-F4F52125-529C-4BB8-B5F4-503AD5D16AC4 Q33902721-C4017805-C911-4CB7-BE6C-EC382FE51AD0 Q34064739-892CCF09-CB02-43B5-87B9-30A7FA6ED282 Q34644175-D1FB3C88-77FB-468B-A15F-6445B044CF52 Q34651135-6EA48CF6-1E65-495A-A2D5-26BBB1AA0349 Q35035669-B68E306A-4B2A-4CF4-9A55-BBB37478D4B2 Q35048396-FB8D64F4-632C-41F7-B687-44101203530C Q35143985-01B06FA2-5860-4418-9241-1636939FB3A8 Q36662808-4CD9FCA0-0720-4DF9-89F6-A0B62839B18B Q36834567-6EBFDBFF-E9FE-44AB-A215-85438AFB8BDA Q36944895-D9C73962-21D0-4272-8C9F-2D07426C3797 Q37363628-CBAEDCB0-0D52-48D1-9398-D128EF53F460 Q37417513-7AFA0F55-BDC6-4F5D-8E55-C38B951CC8CE Q37691974-0DB5E6EF-48ED-432D-B4BD-08E567628EBB Q38086422-A4DC1F8C-6896-4A83-B568-E00EE12981BE Q38218390-E6E5A775-2CD4-4BFC-AEA8-D06C382F007D Q38250091-824E92D1-48C4-4E30-8420-590ADE1E589E Q38270148-2EC20E33-1A2A-46B0-A1D3-C7A496B9ACD8 Q38413816-EFBDD1A7-A3A4-4331-9ABA-8BE0D9E7E4D0 Q38719665-0C0A0BDF-C9C2-4B23-870E-CF6B5BC751AB Q40547789-56B5425E-24EA-4060-B475-6E9C0208A726 Q40968719-04D0778E-952F-4ABF-91F9-4C41C7DA45CA Q44901723-CB1316D8-040B-484C-A056-5560667642A6 Q46709675-DD175479-580F-49CB-80E8-C59824444C42 Q48503003-8C9FB160-6579-46D9-B525-E9EB96D4564E Q53452091-5D055324-14F7-4B63-BB50-460A19B07DA4

P2860

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

http://www.wikidata.org/entity/Q36759184

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

@ast

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

@en

type

label

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

@ast

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

@en

prefLabel

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

@ast

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

@en

P1433

Q36759184-B203B917-2E27-478C-A796-79B3D8309999

P1476

Q36759184-6D2E3305-0839-41C8-A3B4-694A32555CFE

P2093

Q36759184-140CF22E-E78D-4448-A57C-105F8245098A

Q36759184-1F550D22-9354-49AA-92EA-15925B738811

Q36759184-20438B7C-6A5E-4256-B285-E57D181B0080

Q36759184-49C9B7A3-6FB2-4860-8BF6-97B2F5182167

Q36759184-52C7D900-7AB6-43ED-893D-5F8AC0BF29D1

Q36759184-5989B6EE-66BF-439A-9715-A758478CCD0F

Q36759184-63F4D0AE-D2BC-466C-9361-4449508DE855

Q36759184-853E98F4-072E-4167-84B9-3DDC1754575D

Q36759184-9911ECEC-8E3D-48CD-A640-547868108C9A

Q36759184-B3B4D424-0F60-47A7-8B16-ADDE3DBA851E

P2860

Q36759184-012F946B-4D1F-4408-8727-9EF45FF01C00

Q36759184-036E3C94-C694-4822-ACB8-BBEFE183F485

Q36759184-094DFB0D-16DA-4F8D-962B-3ABB647EA0C8

Q36759184-13171EAF-3399-463B-8605-EC0A6D3A550D

Q36759184-16815822-564B-45FB-A41B-C5209638860F

Q36759184-1CB5CF7B-BED4-46A3-A424-00F77907D2A7

Q36759184-1EFEE370-A838-4334-BBAC-6AAE849066FA

Q36759184-2CB66BA9-284B-45AF-A4D0-562A8D339DB2

Q36759184-31F161CA-590B-48CE-91F2-017446E26C71

Q36759184-33E78EAE-916F-4E16-954C-3211DFCCE4AE

P304

Q36759184-B5A5F030-3589-493C-A1A4-1191BE164F36

P31

Q36759184-1EC1A03B-FA02-4ADD-AFB5-F6650334076E

P356

Q36759184-50D793DA-53F9-482C-BA88-9CDEBBD1E477

P433

Q36759184-C73E5BE4-7179-4283-885D-EB966AC5FDB7

P478

Q36759184-5519F8CD-A18C-41AC-A174-81E99D3CC356

P50

Q36759184-9BDCA25E-53A4-444E-9283-D8DEDBBDBDC5

P577

Q36759184-10696A7A-0E50-4B8B-96E5-29905D3C3E6B

P5875

Q36759184-7EE95128-E1E9-40FA-A7E3-5EA87C8F2C90

P698

Q36759184-F9FC6796-EA62-4325-A346-24E97739A320

P932

Q36759184-4B2B33FB-C491-4F17-8EF9-146CA494BBFC

P356

ARCHNEUROL.2011.559

P1433

P1476

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

@en

P2093

Alison C Burggren

http://www.w3.org/2001/XMLSchema#string

Gary W Small

http://www.w3.org/2001/XMLSchema#string

Helen Lavretsky

http://www.w3.org/2001/XMLSchema#string

Jeanne Kim

http://www.w3.org/2001/XMLSchema#string

Jorge R Barrio

http://www.w3.org/2001/XMLSchema#string

Karen J Miller

http://www.w3.org/2001/XMLSchema#string

Linda M Ercoli

http://www.w3.org/2001/XMLSchema#string

Prabha Siddarth

http://www.w3.org/2001/XMLSchema#string

S-C Huang

http://www.w3.org/2001/XMLSchema#string

Susan Y Bookheimer

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

A rating scale for depression

Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Neuropathologic features of amnestic mild cognitive impairment

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Mild cognitive impairment as a diagnostic entity

The role of biomarkers in clinical trials for Alzheimer disease

P304

215-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2011.559

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Helen Lavretsky

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221830395

http://www.w3.org/2001/XMLSchema#string

P698

22332188

http://www.w3.org/2001/XMLSchema#string

P932

3623972

http://www.w3.org/2001/XMLSchema#string